Skandinaviska Enskilda Banken Ab (Publ) Legend Biotech Corp Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $24.3 Billion
- Q3 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Legend Biotech Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 3,100 shares of LEGN stock, worth $98,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,100
Previous 3,100
-0.0%
Holding current value
$98,580
Previous $110,000
8.18%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
234Shares Held
59.9MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$220 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$190 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$182 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$120 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$94.2 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.32B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...